studi
present
new
recombin
protein
act
power
antivir
ravlorecombin
antivir
protein
lonomia
obliqua
abl
reduc
replic
fold
herp
viru
fold
rubella
viru
rtpcr
viral
rna
ravlo
treat
infect
cell
also
show
similar
rate
inhibit
replic
analysi
protein
bioinformat
suggest
protein
globular
secret
signal
peptid
abil
bind
mhc
class
found
sever
protein
bind
site
variou
hla
preval
ahelic
ntermin
region
overal
classifi
ab
protein
type
blast
similar
sequenc
search
correspond
cdna
reveal
similar
sequenc
genbank
suggest
novel
protein
famili
studi
observ
recombin
protein
hemolymph
potent
antivir
action
protein
produc
system
therefor
analys
suggest
novel
polypeptid
candid
broad
spectrum
antivir
viral
infect
subject
consider
interest
especi
human
anim
plant
health
field
still
mani
diseas
effici
treatment
avail
search
new
strategi
extrem
import
develop
agent
also
import
overcom
frequent
occurr
microorgan
resist
drug
lohner
staudegg
therefor
new
therapi
human
viral
diseas
strongli
reli
discoveri
new
therapeut
agent
kao
et
al
influenza
treatment
exampl
four
antivir
agent
approv
current
use
howev
kao
cowork
alreadi
report
could
easili
develop
resist
tamiflu
base
gene
sequenc
structur
predict
neuraminidas
zanamivir
agent
also
belong
neuraminidas
inhibitor
class
activ
influenza
b
drug
amantadin
rimantadin
belong
adamantan
class
known
effect
influenza
viru
fior
et
al
antivir
activ
also
describ
mani
bioproduct
investig
new
drug
develop
product
produc
anim
plant
bacteria
nowaday
develop
new
therapi
import
diseas
aid
acquir
immuno
defici
syndrom
caus
new
strain
virus
sar
coronaviru
influenza
virus
major
topic
delcroix
riley
heinen
da
veiga
insect
highlight
scenario
sever
studi
demonstr
antivir
effect
substanc
synthet
group
fact
organ
found
inhabit
planet
ecosystem
lead
believ
develop
protect
mechan
surviv
place
suscept
varieti
viral
infect
insect
resist
mechan
present
littl
known
identif
pathway
stimul
search
new
agent
appli
human
infect
chernysh
et
al
yao
et
al
antivir
activ
molecul
found
differ
compound
insect
speci
chernysh
et
al
cueto
et
al
ourth
popham
et
al
recent
identifi
protein
avlo
approxim
kda
purifi
hemolymph
lonomia
obliqua
abl
inhibit
replic
measl
polio
influenza
virus
ad
cell
cultur
h
infect
greco
et
al
observ
studi
hemolymph
show
virucid
effect
suggest
may
act
differ
stage
viru
replic
anoth
studi
protein
success
express
baculoviru
system
antivir
activ
test
show
purifi
recombin
protein
could
significantli
reduc
viral
replic
time
picornaviru
emc
carmo
et
al
therefor
antivir
activ
confirm
develop
vitro
express
led
us
proceed
investig
new
protein
featur
understand
structur
function
mechan
action
macromolecul
essenti
evalu
potenti
establish
wide
rang
antivir
agent
present
studi
test
antivir
activ
herp
rubella
viru
character
physic
biolog
properti
novel
protein
l
obliqua
hemolymph
differ
silico
approach
protein
present
antivir
activ
sever
viru
infect
cell
cultur
describ
previou
studi
group
carmo
et
al
greco
et
al
therefor
protein
properti
instig
attent
potenti
new
antivir
drug
elucid
properti
mechan
action
great
step
drug
develop
sirc
cell
rabbit
atcc
manassa
va
usa
vero
cell
line
african
green
monkey
kidneyatcc
grown
cm
plastic
cell
cultur
flask
dmem
medium
dulbecco
minimum
eagl
essenti
medium
supplement
inact
fetal
bovin
serum
fb
mm
lglutamin
invitrogen
carlsbad
ca
usa
studi
hemolymph
l
obliqua
collect
sixth
instar
larva
seta
cut
purifi
fraction
obtain
gel
filtrat
chromatographi
system
describ
greco
et
al
cytotox
effect
hemolymph
assess
use
standard
vero
cell
assay
confluent
cell
cultur
expos
differ
amount
hemolymph
vv
incub
h
triplic
analysi
perform
h
incub
daili
supernat
remov
remain
live
cell
count
fix
stain
crystal
violet
methanol
cytotox
percentag
valu
calcul
formula
control
sampl
control
data
express
mean
sd
statist
analysi
perform
use
student
test
level
signific
set
p
b
antivir
protein
use
studi
recombin
protein
l
obliqua
express
baculovirusinsect
cell
system
describ
carmo
et
al
vero
sirc
cell
cultiv
approxim
confluenc
well
plate
dmem
supplement
mm
lglutamin
fc
plate
incub
humidifi
co
atmospher
confluent
cell
inocul
purifi
hemolymph
clone
empti
bacmid
recombin
ravlo
clone
ravlo
clone
ravlo
clone
duplic
h
incub
cell
infect
virus
infect
cultur
dilut
rubella
viru
herp
viru
follow
incub
previous
describ
day
addit
determin
hemolymph
effect
infect
cell
real
time
pcr
perform
confluent
monolay
dispers
trypsin
versen
resuspend
dmem
growth
medium
iuml
penicillin
g
mgml
streptomycin
prepar
well
plate
cell
suspens
dilut
cellsml
plate
seed
suspens
incub
humidifi
co
atmospher
ra
strain
meruvax
ii
merck
sharp
dohm
herp
simplex
viru
strain
mc
intyr
stock
viru
quantifi
medium
tissuecultur
infect
moi
multipl
infect
cell
cultur
confluent
cell
cultur
inocul
dilut
viru
quadrupl
cell
line
h
adsorpt
room
temperatur
well
receiv
dmem
medium
fb
uninfect
cultur
also
prepar
treat
ident
control
plate
cultur
observ
cpe
daili
day
test
conclud
fifti
per
cent
infect
end
point
calcul
method
reed
muench
titer
given
log
tcid
per
ml
viru
vero
sirc
cell
seed
well
plate
cell
per
well
incub
h
co
confluent
cell
inocul
purifi
hemolymph
empti
bacmid
clone
recombin
clone
ravlo
clone
ravlo
clone
ravlo
clone
carmo
et
al
incub
humidifi
co
atmospher
h
cell
infect
virus
infect
cultur
dilut
rate
rubella
viru
herp
viru
plaqu
format
assess
day
stain
crystal
violet
fixat
cell
paraformaldehyd
number
plate
count
manual
pfu
number
present
averag
duplic
sampl
experi
repeat
least
three
time
total
rna
extract
type
cultur
infect
non
infect
use
magna
pure
extractor
roch
basel
switzerland
rubella
viru
rtpcr
perform
use
superscript
iii
step
rtpcr
invitrogen
accord
manufactur
recommend
amplifi
region
code
region
nucleotid
describ
abernathi
et
al
assay
perform
triplic
reaction
mixtur
contain
reaction
buffer
invitrogen
superscripttaq
enzym
mixtur
lm
primer
lm
label
probe
invitrogen
rna
assay
carri
triplic
sampl
includ
notempl
control
thermal
cycl
carri
appli
biosystem
thermal
cycl
min
min
cycl
min
presenc
intact
rna
sampl
confirm
specif
prime
rnasep
rna
emeri
et
al
four
posit
control
contain
known
copi
number
transcrib
rv
rna
run
plate
quantit
standard
reaction
mixtur
contain
water
templat
run
plate
neg
control
data
analyz
sd
softwar
version
ab
herp
simplex
viru
quantit
real
time
pcr
assay
use
primer
describ
read
kurtz
real
time
pcr
solut
contain
sybr
green
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
lm
primer
h
cdna
cycl
condit
follow
min
follow
cycl
cdna
nucleic
acid
respect
amino
acid
sequenc
antivir
activ
protein
obtain
genbank
acess
number
antivir
activ
sequenc
describ
previou
publish
work
carmo
et
al
greco
et
al
sequenc
edit
perform
bioedit
cdna
amino
acid
sequenc
submit
blastp
basic
local
align
search
tool
order
identifi
region
similar
sequenc
alreadi
describ
literatur
first
instanc
determin
sequenc
could
relat
intrins
unstructur
type
protein
use
intrins
unstructur
predictor
server
iupr
techniqu
estim
pairwis
energi
amino
acid
composit
classifi
fold
disord
protein
three
type
predict
perform
long
disord
short
disord
structur
region
queri
sequenc
protein
known
determin
structur
disord
region
hepat
c
viru
nonstructur
region
genbank
access
number
iupr
access
http
iupr
enzimhu
dosztanyi
et
al
predict
secondari
structur
type
helix
sheet
coil
perform
use
differ
approach
dispon
phyre
predictprotein
platform
postransl
modif
site
perform
use
prosit
predictprotein
server
phyre
dispon
http
wwwsbgbioicacukphyr
kelley
sternberg
predictprotein
avail
http
wwwpredictproteinorg
rost
et
al
verifi
difficulti
get
structur
protein
experiment
use
protein
crystallographi
sequenc
submit
xtalpr
server
predict
protein
crystalliz
analyz
sever
featur
protein
comput
featur
program
return
result
overal
probabl
crystal
xtalpr
avail
http
ffasburnhamorgxtalpredcgixtalpl
slabinski
et
al
use
interproscan
sequenc
search
tool
emblebi
http
wwwebiacuktoolspfaiprscan
recogn
sequenc
differ
protein
signatur
databas
interproscan
combin
sever
method
refin
procedur
wide
use
structur
function
classif
hunter
et
al
signalp
server
use
predict
presenc
local
signal
peptid
cleavag
site
method
base
combin
sever
artifici
neural
network
ann
consid
one
best
method
search
signal
peptid
petersen
et
al
combin
signalp
targetp
server
predict
subcellular
local
eukaryot
protein
local
assign
base
predict
presenc
aminotermin
presequ
emanuelsson
et
al
signalp
targetp
avail
center
biolog
sequenc
cb
websit
http
wwwcbsdtudkservic
overal
weight
pi
isoeletr
point
gravi
grand
averag
hydropath
estim
protparam
http
webexpasyorgcgibinprotparam
protparam
protscal
predict
server
http
web
expasyorgprotscal
analyz
sequenc
order
predict
sever
physic
chemic
properti
differ
method
amino
acid
sequenc
submit
avail
scale
polar
hydrophob
access
mutabl
residu
posit
predict
vivo
protein
could
region
interact
mhc
netclt
http
wwwcbsdtudk
servicesnetctl
databas
use
identifi
sequenc
peptid
motif
could
bind
method
integr
predict
peptid
mhc
class
bind
proteasom
c
termin
cleavag
tap
transport
effici
server
allow
predict
ctl
epitop
restrict
mhc
class
supertyp
mhc
class
bind
proteasom
cleavag
predict
perform
use
artifici
neural
network
tap
transport
effici
predict
use
weight
matrix
larsen
et
al
score
mean
sensit
specif
consid
verifi
differ
predict
result
signific
p
valu
submit
twoproport
test
fisher
exact
test
use
softwar
minitab
minitab
inc
state
colleg
pa
usa
hemolymph
concentr
lower
vv
toxic
vero
sirc
cell
sinc
high
percentag
viabl
cell
observ
throughout
triplic
cytotox
determin
experi
antivir
activ
total
hemolymph
recombin
clone
test
rubella
herp
simplex
virus
clone
ad
infect
sirc
vero
cell
cultur
h
prior
infect
cell
pretreat
recombin
show
decreas
herp
viru
titer
comparison
control
cultur
cell
without
treatment
experi
carri
rubella
viru
show
similar
result
use
clone
caus
decreas
rubella
viru
titer
summari
result
cpe
reduct
assay
demonstr
total
hemolymph
exhibit
antivir
effect
ad
pre
postinfect
even
simultan
viru
inhibitori
effect
total
hemolymph
power
recombin
test
identifi
inhibitori
effect
hemolymph
rubella
herp
replic
viral
genom
synthesi
rubella
herp
compar
hemolymph
treat
untreat
infect
cell
total
rna
dna
extract
perform
h
rubella
herp
infect
intracellular
viral
load
virus
measur
standard
curv
amplif
gener
serial
tenfold
dilut
templat
evalu
effici
reaction
result
standard
curv
show
amplif
effici
gene
correl
coeffici
greater
result
qpcr
show
significantli
increas
level
rubella
herp
transcript
inocul
cell
day
viral
infect
compar
mock
also
reduct
rubella
viru
observ
cell
treat
ravlo
clone
total
hemolymph
dilut
fig
reduct
herp
viru
replic
observ
cell
treat
recombin
dilut
addit
total
hemolymph
complet
inhibit
replic
herp
viru
fig
blast
analysi
cdna
sequenc
without
histidin
tail
tev
tobacco
etch
viru
proteas
site
nucleic
acid
residu
result
identif
sequenc
similar
genbank
respect
protein
sequenc
analysi
amino
acid
residu
identifi
low
similar
region
carnitin
acetyl
transferas
access
number
genbank
coverag
region
residu
queri
protein
residu
refer
sequenc
amino
acid
sequenc
cover
full
queri
sequenc
encount
iupr
analysi
indic
amino
acid
sequenc
overal
fold
conform
therefor
show
globular
form
detail
program
return
identifi
long
region
high
disord
tendenc
dt
posit
probabl
dt
accord
iupr
short
disord
region
possibl
residu
disord
tendenc
around
respect
accord
two
previou
describ
predict
iupr
predict
structur
region
show
protein
extens
tendenc
show
globular
structur
result
protein
known
region
structuredisord
accord
result
experi
structur
part
posit
disord
region
summari
queri
amino
acid
sequenc
predict
predictprotein
server
alphabeta
type
second
structur
gener
architectur
overal
protein
composit
helix
sheet
coil
phyre
server
predict
structur
composit
helix
sheet
coil
statist
analysi
demonstr
result
two
serv
signific
differ
p
along
protein
sequenc
helix
structur
type
identifi
least
two
portion
ntermin
region
high
confid
one
residu
contrast
helix
coil
structur
type
identifi
distribut
overal
sequenc
comprehend
long
portion
helix
maximum
residu
prosit
analysi
indic
phosphoryl
myristoyl
modif
site
summari
predict
shown
fig
predict
difficulti
obtain
crystallographi
structur
xtalpr
protein
classifi
sequenc
median
difficulti
interproscan
identifi
one
known
signatur
amino
acid
sequenc
eukaryot
signal
peptid
aminotermin
portion
accord
signalp
predict
show
detail
sequenc
site
maximum
cleavag
probabl
residu
probabl
hydrogenregion
consid
result
targetp
predict
protein
secret
presequ
length
residu
reliabl
class
reliabl
class
divid
indic
strongest
predict
rc
measur
size
differ
diff
highest
win
second
highest
output
score
class
indic
diff
overal
protein
molecular
weight
predict
result
kda
cleavag
predict
targetp
two
result
fragment
kda
theoret
pi
gravi
also
chang
overal
sequenc
predict
fragment
pi
gravi
cleavag
pi
gravi
small
fragment
pi
gravi
long
fragment
predict
polar
hydrophob
posit
protscal
indic
protein
show
aminoterminu
highli
hydrophob
nonpolar
near
residu
fragment
sequenc
altern
polar
nonpolar
region
around
residu
length
residu
follow
carboxi
terminu
show
slightli
increas
hydrophob
polarhydrophil
region
locat
residu
fig
accord
result
predict
access
buri
residu
show
right
probabl
hydrophil
region
expos
overal
structur
fig
rel
mutabl
analysi
show
first
residu
around
residu
mutabl
lowest
hand
residu
follow
residu
highest
valu
mutabl
shown
fig
netclt
predict
potenti
epitop
protein
sequenc
epitop
predict
concentr
two
region
aminotermin
residu
central
region
schemat
pictur
summar
predict
built
fig
expans
number
applic
antivir
drug
remark
mainli
last
decad
exampl
current
repertoir
new
antivir
drug
antihiv
anticmv
antihsv
antivzv
antirsv
antihepat
virus
antiinfluenza
virus
de
clercq
develop
new
antivir
subject
recent
expans
thu
still
plenti
improv
need
de
clercq
field
bioinformat
tool
play
essenti
role
combin
fast
reliabl
wide
rang
applic
softwar
analysi
import
advantag
tool
help
new
drug
investig
butt
ito
wishart
herp
simplex
viru
hsv
common
human
pathogen
viru
clinic
hsv
infect
may
give
rise
gingivostomat
cold
sore
kerat
enceph
genit
herp
use
sever
glycoprotein
receptor
complex
enter
host
cell
genotyp
express
glycoprotein
gb
gc
gd
geh
gl
except
gc
essenti
viral
entri
although
absenc
gc
reduc
effici
gc
make
first
contact
host
cell
bind
heparin
sulfat
hs
proteoglycan
cell
surfac
bernard
et
al
herp
simplex
viru
enter
cell
two
pathway
fusion
envelop
plasma
membran
endocytosi
first
one
depend
interact
specif
receptor
cell
surfac
second
auxiliari
pathway
involv
endocytosi
envelop
capsid
receptordepend
fusion
envelop
membran
endocyt
vesicl
pathway
requir
initi
revers
attach
cell
surfac
bernard
et
al
first
step
entri
involv
bind
virion
gc
gb
protein
cellsurfac
glycosaminoglycan
gag
import
step
demonstr
observ
enzymat
remov
gag
result
fold
decreas
effici
plaqu
format
studi
found
hemolymph
exhibit
select
inhibitori
effect
four
probabl
pathway
might
deduc
antivir
effect
abernathi
et
al
blockag
viral
bind
cell
receptor
oneil
et
al
attenu
viral
replic
entri
emeri
et
al
inhibit
viru
releas
host
cell
read
kurtz
reduct
inflammatori
cytokin
storm
induc
viru
infect
result
show
antivir
effect
preincub
treatment
present
cpe
reduct
assay
higher
inhibitori
activ
simultan
treatment
recombin
total
hemolymph
moreov
corrobor
antivir
activ
qpcr
assay
use
test
vitro
effect
hemolymph
viral
multicolor
bar
indic
epitop
recogn
one
allel
color
figur
onlin
replic
fig
olicard
et
al
show
addit
hemolymph
c
giga
vero
cell
cultur
prior
infect
affect
subsequ
infect
thu
inhibitori
action
hemolymph
viral
replic
may
activ
ifn
pathway
recent
melchjorsen
et
al
show
initi
respons
cell
infect
hsv
secret
antivir
substanc
defensin
nitric
oxid
importantli
product
cytokin
includ
ifn
chemokin
type
ifn
ifnab
key
cytokin
produc
first
hour
hsv
infect
vivo
studi
show
ifnab
alon
control
earli
hsv
infect
independ
natur
killer
nk
cell
lymphocyt
activ
bernard
et
al
therefor
although
studi
establish
import
role
ifnab
antivir
defens
difficult
determin
whether
ifnab
contribut
viral
clearanc
primarili
mediat
direct
antivir
mechan
indirect
immunoregulatori
mechan
addit
ifnk
induc
antivir
state
cell
janu
kinasesign
transduc
activ
transcript
jak
stat
pathway
kotenko
sheppard
et
al
earli
hsv
infect
activ
multipl
cellular
transcript
factor
nfjb
mapk
irf
also
coordin
melchjorsen
et
al
although
therapeut
diagnost
improv
control
hsv
develop
last
year
viru
mean
control
outcom
hsv
infect
depend
balanc
viru
propag
effect
immun
respons
appropri
express
ifn
cytokin
chemokin
essenti
effici
host
defens
infect
mayb
mechan
hemolymph
includ
induct
ifn
ab
express
current
studi
suggest
hypothesi
rubella
classifi
togavirida
famili
viru
contain
singlestrand
rna
genom
member
separ
genu
call
rubiviru
viru
particl
diamet
nm
nucleocapsid
exhibit
cubic
symmetri
surround
lipoprotein
envelop
project
consist
two
glycoprotein
high
gc
content
distinguish
characterist
viral
genom
hobman
chantler
consequ
organ
affect
fetus
infant
number
cell
lower
healthi
one
rubella
also
induc
damag
apoptosi
vitro
studi
suggest
effect
due
rubellainduc
caspasedepend
mechan
detail
mechan
still
unclear
seem
depend
viru
replic
start
within
h
infect
pathway
seem
involv
howev
nonhuman
cell
although
viral
replic
requir
induc
apoptosi
noninfect
neighbor
cell
undergo
effect
addit
ifn
c
restrict
viral
replic
reduc
level
viral
rna
cell
inhibit
viral
translat
interestingli
stanwick
hallum
found
cell
persist
infect
rubv
bhk
hamster
cell
lack
type
ifn
receptor
rabbit
hela
human
cure
similar
level
exogen
ifn
administr
conclus
rubv
persist
infect
cell
cultur
surprisingli
resist
ifn
treatment
like
contribut
abil
rubv
establish
persist
infect
rubella
transcript
level
also
affect
presenc
total
hemolymph
ravlo
clone
fig
base
advantag
silico
tool
present
studi
propos
use
bioinformat
avail
softwar
describ
novel
protein
show
antivir
activ
analys
show
mani
interest
characterist
protein
protein
show
signal
peptid
secret
cleav
result
agre
previou
experiment
analysi
show
protein
hemolymph
compon
greco
et
al
hemolymph
product
differ
arthropod
potenti
candid
treat
differ
diseas
human
bodi
promis
anticanc
agent
wu
et
al
antithrombot
guerrero
et
al
antimicrobi
agent
gazit
et
al
slocinska
et
al
exampl
overal
hydrophob
analysi
show
protein
hydrophil
gravi
predominantli
fold
region
fold
essenti
defin
stabl
conform
peptid
potluri
et
al
therefor
summari
bioinformat
analysi
indic
physic
chemic
properti
protein
may
stabl
enough
allow
success
experiment
analysi
structur
interact
furthermor
prosit
search
recogn
potenti
posttransl
modif
site
fig
potenti
phosphoryl
site
identifi
posit
addit
phosphoru
atom
protein
lead
revers
modif
protein
structur
mechan
use
cell
signal
regulatori
pathway
olsen
et
al
myristoyl
site
found
two
posit
protein
coval
myrist
bind
revers
alter
protein
hydrophob
import
structur
mainten
macromolecul
gordon
et
al
moreov
silico
result
point
candid
region
interact
cellviru
fig
access
polar
mhc
bind
point
highli
expos
region
residu
although
experiment
analys
still
need
confirm
region
could
interact
viru
cellular
protein
inhibit
establish
viral
infect
primarili
earli
stage
infect
summar
studi
cpe
assay
result
show
reduct
replic
virus
addit
qpcr
result
indic
small
inhibit
unlik
occur
vero
cell
inocul
herp
bioinformat
analysi
indic
interest
result
protein
seem
present
fold
hydrophil
profil
compat
futur
crystallographi
essay
fig
possibl
region
interact
cellular
andor
viral
protein
also
identifi
fig
conclud
novel
protein
hemolymph
may
act
potent
antivir
agent
differ
viru
type
envelop
virus
rubella
viru
herp
viru
measl
viru
nonenvelop
virus
picornaviru
genom
dna
virus
herp
viru
rna
virus
influenza
viru
measl
viru
picornaviru
carmo
et
al
greco
et
al
analys
understand
mechan
action
applic
vivo
essenti
howev
previou
present
result
conclud
macromolecul
potenti
becom
promis
antivir
agent
broad
spectrum
activ
